Latest Breaking News On - Clinformatics data mart database - Page 1 : comparemela.com

Inappropriate antibiotic prescriptions dropped early in pandemic, rebounded in 2021

The average number of inappropriate antibiotics prescribed monthly decreased at the start of the COVID-19 pandemic but returned to pre-pandemic levels by late 2021, data show.

United statesShenaz baghaBycaitlyn stulpinUniversity of michigan medical schoolPing chuaMichigan medical schoolAdobe stockClinformatics data mart databaseMedicare advantage

Perinatal PTSD significantly increased from 2008 to 2020, varying based on race, ethnicity

Perinatal PTSD significantly increased from 2008 to 2020, varying based on race, ethnicity
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesAnn arborRichard smithStephaniev hallSharon dekel tsvetkovByerint welshHealth affairsUniversity of michiganHealth aff millwoodHealth affClinformatics data mart database

Out-of-Pocket Insulin Caps Boost Savings -- But Not Insulin Use

Proposed national $35 insulin cap would help some patients, researchers say

New mexicoUnited statesNew yorkHealth care instituteDistrict of columbiaLaura garabedianHarvard pilgrim health care instituteHarvard medical schoolUnion addressesPresident bidenClinformatics data mart databaseNew york cityIntern med

Kidney Stone Risk Lower With SGLT2 Inhibitor vs Other Diabetes Drug Classes

The association between SGLT2i use and kidney stone risk was similar by race and ethnicity, sex, obesity, and history of chronic kidney disease. Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.

United statesJuliem paikClinformatics data mart databaseMedicare fee for service parts

Kidney Stone Risk Lower With SGLT2 Inhibitor vs Other Diabetes Drug Classes

Adult patients with type 2 diabetes (T2D) who use a sodium-glucose cotransporter 2 inhibitor (SGLT2i) rather than other classes of glucose-lowering agents Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.

United statesJuliem paikClinformatics data mart databaseMedicare fee for service parts